Indications and Adverse Events of Toradol: Based on FDA Adverse Event Reporting System (FAERS)

Our findings, derived from hypothesis-generating signal detection analyses, provide real-world safety data on Toradol, highlighting high-risk AEs and reporting biases. Enhanced vigilance and monitoring, especially in high-risk populations, are imperative. However, these signals require confirmation through prospective, controlled studies to establish causality.